Elevai Labs Inc (ELAB) Stock Price, Quote & News

Company Profile

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The compan...

Industry: Biotechnology

Sector: Healthcare

Phone: 866-445-4886

Website: pmgcholdings.com

Address:

120 Newport Center Drive, Suite 249, Newport Beach, United States

i8j0momma666 Jun. 26 at 4:17 PM

$ELAB 141.93%. https://chartexchange.com/symbol/nasdaq-elab/borrow-fee/ .

0 · Reply

i8j0momma666 Jun. 25 at 3:38 PM

$ELAB 126.98%. https://chartexchange.com/symbol/nasdaq-elab/borrow-fee/ .

0 · Reply

jc1122 Jun. 24 at 8:52 PM

$ELAB setting up nicely to break out of current setup by tomorrow mid day. $IXHL another day closer to july release of topline data, already received ultra fast approval for phase 3, $HCTI late today it broke out of setup and now theyre hammering it in AH providing a nice entry price before continuation tomorrow, PT .20 for an almost +500 percent gain. Bargain of the day: $MLGO sub .58 right now, .576 pivot point. Good luck everyone

0 · Reply

Stock_Catcher Jun. 24 at 8:18 PM

$ELAB nice chart.

0 · Reply

Shrimp123 Jun. 24 at 4:54 PM

$ELAB 4$ soon

0 · Reply

i8j0momma666 Jun. 24 at 4:23 PM

$ELAB 132.04%. https://chartexchange.com/symbol/nasdaq-elab/borrow-fee/ .

0 · Reply

Stock_Catcher Jun. 24 at 3:34 PM

$ELAB 1 m float bio mentioned earlier swing idea , slowly perking light volume

0 · Reply

Stock_Catcher Jun. 24 at 1:50 PM

$ELAB one of those stocks that always spikes in the mornings . Looking good. Had news 1 hour ago, bios are ripping today like $INM $VOR $IBIO

1 · Reply

Stock_Catcher Jun. 24 at 1:43 PM

$VOR $INM mentioned both not long ago , ripping huge. $ELAB and $DSS are up less than 5% right now , both micro float , both big range on daily chart , both had news just like 1 hour ago.

0 · Reply

Stock_Catcher Jun. 24 at 1:36 PM

$WFF halted up just now . anotha one. $ELAB and $DSS looking at next after big green gains on $RGC and $WFF pops

1 · Reply

PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue

Jun 18, 2025, 9:52 AM EDT - 8 days ago

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

Jun 17, 2025, 9:04 AM EDT - 9 days ago

Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases

Jun 16, 2025, 8:00 AM EDT - 10 days ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years

Jun 9, 2025, 8:00 AM EDT - 17 days ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company

May 22, 2025, 8:16 AM EDT - 5 weeks ago

NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia

May 14, 2025, 4:30 PM EDT - 6 weeks ago

PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q

May 14, 2025, 8:00 AM EDT - 6 weeks ago

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)

TCRT

Apr 29, 2025, 12:15 PM EDT - 2 months ago

RESEND - Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health

Apr 28, 2025, 8:00 AM EDT - 2 months ago

Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial

Apr 16, 2025, 8:00 AM EDT - 2 months ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company

Apr 7, 2025, 5:30 PM EDT - 2 months ago

Nestpoint Group Fuels Univest Securities, LLC's Ascent to Investment Banking Powerhouse in Trump's Economic Golden Age

BON

Mar 28, 2025, 8:00 AM EDT - 3 months ago

PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K

Mar 27, 2025, 8:00 AM EDT - 3 months ago

NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market

Mar 24, 2025, 5:00 PM EDT - 3 months ago

Univest Securities, LLC Announces Closing of $1.48 Million Registered Direct Offering for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

Mar 21, 2025, 2:41 PM EDT - 3 months ago

PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules

Mar 21, 2025, 8:00 AM EDT - 3 months ago

PMGC Holdings Announces Share Repurchases from Existing Shareholders

Feb 27, 2025, 8:00 AM EST - 4 months ago

PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group

Feb 26, 2025, 8:30 AM EST - 4 months ago

PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market

Feb 4, 2025, 8:00 AM EST - 5 months ago

Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1

Jan 31, 2025, 10:33 AM EST - 5 months ago

PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

Jan 28, 2025, 5:00 PM EST - 5 months ago

Univest Securities, LLC Announces Closing of $1.92 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

Jan 27, 2025, 9:00 AM EST - 5 months ago

PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors

Jan 24, 2025, 8:00 AM EST - 5 months ago

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium

Jan 16, 2025, 8:31 AM EST - 5 months ago

PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture

Jan 15, 2025, 9:30 AM EST - 5 months ago

PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries

Jan 2, 2025, 3:55 PM EST - 6 months ago

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy

Dec 20, 2024, 7:30 PM EST - 6 months ago

Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Dec 20, 2024, 7:30 AM EST - 6 months ago

Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Dec 6, 2024, 7:30 AM EST - 7 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market

Nov 22, 2024, 6:23 PM EST - 7 months ago

Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance

Nov 22, 2024, 5:00 PM EST - 7 months ago

Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess

Nov 14, 2024, 2:35 PM EST - 8 months ago

CORRECTION - Elevai Labs Inc.

Nov 14, 2024, 9:08 AM EST - 8 months ago

Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update

Nov 4, 2024, 5:45 PM EST - 8 months ago

Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange

Oct 22, 2024, 9:54 AM EDT - 8 months ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity

Oct 21, 2024, 7:30 AM EDT - 8 months ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

Oct 4, 2024, 5:08 PM EDT - 9 months ago

Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock

Oct 3, 2024, 3:45 PM EDT - 9 months ago

REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

Oct 3, 2024, 7:30 AM EDT - 9 months ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

Oct 2, 2024, 8:30 AM EDT - 9 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device

Sep 24, 2024, 5:00 PM EDT - 9 months ago

Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB)

Sep 23, 2024, 2:35 PM EDT - 9 months ago

Dow Gains Over 50 Points; Elevai Labs Shares Plummet

Sep 23, 2024, 8:45 AM EDT - 9 months ago

Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering

Sep 10, 2024, 7:30 AM EDT - 10 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications

Sep 3, 2024, 7:30 AM EDT - 10 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology

Aug 28, 2024, 7:30 AM EDT - 10 months ago

Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™

Aug 26, 2024, 7:30 AM EDT - 10 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum

Aug 19, 2024, 9:00 AM EDT - 11 months ago

Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications

Aug 14, 2024, 9:05 AM EDT - 11 months ago

Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

i8j0momma666 Jun. 26 at 4:17 PM

$ELAB 141.93%. https://chartexchange.com/symbol/nasdaq-elab/borrow-fee/ .

0 · Reply

i8j0momma666 Jun. 25 at 3:38 PM

$ELAB 126.98%. https://chartexchange.com/symbol/nasdaq-elab/borrow-fee/ .

0 · Reply

jc1122 Jun. 24 at 8:52 PM

0 · Reply

Stock_Catcher Jun. 24 at 8:18 PM

$ELAB nice chart.

0 · Reply

Shrimp123 Jun. 24 at 4:54 PM

$ELAB 4$ soon

0 · Reply

i8j0momma666 Jun. 24 at 4:23 PM

$ELAB 132.04%. https://chartexchange.com/symbol/nasdaq-elab/borrow-fee/ .

0 · Reply

Stock_Catcher Jun. 24 at 3:34 PM

$ELAB 1 m float bio mentioned earlier swing idea , slowly perking light volume

0 · Reply

Stock_Catcher Jun. 24 at 1:50 PM

$ELAB one of those stocks that always spikes in the mornings . Looking good. Had news 1 hour ago, bios are ripping today like $INM $VOR $IBIO

1 · Reply

Stock_Catcher Jun. 24 at 1:43 PM

$VOR $INM mentioned both not long ago , ripping huge. $ELAB and $DSS are up less than 5% right now , both micro float , both big range on daily chart , both had news just like 1 hour ago.

0 · Reply

Stock_Catcher Jun. 24 at 1:36 PM

$WFF halted up just now . anotha one. $ELAB and $DSS looking at next after big green gains on $RGC and $WFF pops

1 · Reply

Stock_Catcher Jun. 24 at 1:33 PM

$ELAB another stock that had news earlier micro floater. no volume right now.

0 · Reply

Shrimp123 Jun. 24 at 1:10 PM

$ELAB

0 · Reply

FreedomGladiator Jun. 24 at 1:08 PM

$ELAB - Here we go! We did $2.60 this morning!

0 · Reply

Stock_Catcher Jun. 24 at 12:32 PM

$ELAB 1 m float acquisition news.

0 · Reply

Stock_Catcher Jun. 24 at 12:30 PM

$ELAB moving

0 · Reply

i8j0momma666 Jun. 24 at 1:27 AM

$ELAB .

0 · Reply

i8j0momma666 Jun. 23 at 3:52 PM

$ELAB .

0 · Reply

FreedomGladiator Jun. 23 at 3:27 PM

$ELAB - $$$

0 · Reply

FreedomGladiator Jun. 23 at 3:26 PM

$ELAB - June 16, 2025 – PMGC Holdings Inc. (Nasdaq:ELAB) (the “Company,” “PMGC,” “we,” or “us”), a diversified public holding company, is pleased to announce the signing of a non-binding Letter of Intent (“LOI”) to acquire a California-based, cash-flow positive computer numerical control (“CNC”) machining company with over 35 years of operational history.

0 · Reply

FreedomGladiator Jun. 23 at 3:25 PM

$ELAB - June 17, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), today announced the initiation of Phase II of the AI Development Program with strategic partner Yuva Biosciences, Inc. (“YuvaBio”).

0 · Reply

Bluesclues692 Jun. 22 at 9:19 PM

$ELAB feels gud

0 · Reply

1Asianstockthoughts Jun. 21 at 5:54 PM

$ELAB we will see what this coming week brings… ELAB recently completed a 1-for-7 reverse stock split on March 10, 2025 to comply with Nasdaq’s minimum bid price requirement. Under the updated Nasdaq listing rules (Rule 5810/5815) enacted January 17, 2025, the company faces critical limitations: • Only one reverse split allowed per 12‑month period • One 180‑day compliance extension window allowed, which ELAB just used If ELAB drops below the $1 minimum again—or below $0.10 for 10 consecutive trading days—it could face automatic delisting with no further compliance period No more chances, all of the other biotechs followed this similar pattern. The following weeks will show.

2 · Reply

Market Cap	6.63M
Revenue (ttm)	1.71M
Net Income (ttm)	-4.30M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-251.46%
Debt to Equity Ratio	0.06

Volume	378,291
Avg Vol	1,507,805
Day's Range	N/A - N/A
Shares Out	2.59M
Stochastic %K	44%
Beta	N/A
Analysts	Strong Buy
Price Target	N/A